Kaylan Sliney


Sliney, Kaylan

Kaylan Sliney is an experienced corporate lawyer who focuses her practice on mergers and acquisitions and corporate reorganizations. She has represented early-stage high technology and software companies in all aspects of formation, debt and equity financing, and operations through exit, including employment and equity incentive matters, contract negotiation and licensing.

Prior to joining the firm, Ms. Sliney was a corporate associate at Brown Rudnick LLP.

Previously, Ms. Sliney was a senior legal and policy fellow with the Polaris Project, a US-based human rights organization working to end modern-day slavery and human trafficking in the United States and around the world. While there, she drafted commentary and edited text of the national Model Provisions of Comprehensive State Legislation to Combat Human Trafficking. She also assisted in providing state senate testimony, and lobbied policy movement regarding anti-human trafficking legislation for 13 states. The year prior, Ms. Sliney was a research associate at the Public International Law and Policy Group in Washington DC, where she advised the Sri Lankan government on human trafficking, devolution of political power, post-conflict economic development and disarmament processes.

Professional Activities

Ms. Sliney is a member of the American Bar Association.

Publications & News


March 9, 2018

WilmerHale Counsels Stash in $37.5M Series D Funding

Stash, the financial platform revolutionizing how millions of Americans invest and save, announced it has raised $37.5 million in Series D funding.

February 8, 2018

WilmerHale Advises on the Formation of Valence Media, a New Diversified Media Company

WilmerHale served as legal counsel in connection with the creation of Valence Media, a new diversified media company formed through the combination of three successful media companies: Billboard-Hollywood Reporter Media Group, dick clark productions and MRC.

December 15, 2017

WilmerHale Reps Decibel Therapeutics in Strategic Collaboration With Regeneron

On November 29, 2017, Regeneron Pharmaceuticals, Inc. and Decibel Therapeutics, Inc. announced a collaboration to discover and develop new potential therapeutics to protect, repair and restore hearing.

July 14, 2017

WilmerHale Represents Stash in Securing $40M in Series C Funding

Stash, a financial technology platform revolutionizing investment and financial literacy across the US, announced that it has raised $40 million in Series C funding.

May 8, 2017

WilmerHale Represents Genpact in Acquisition of BrightClaim

Genpact, a global professional services firm focused on delivering digital transformation for clients, announced that it has acquired BrightClaim and its associated company National Vendor.

November 11, 2016

WilmerHale Advises Memorial Sloan Kettering, The Rockefeller University and Weill Cornell Medicine in Establishment of Bridge Medicines

Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medicine announced that they established a new drug discovery company called Bridge Medicines.

August 2, 2016

WilmerHale Partnership with Leading FinTech Accelerator Culminates in First NY Demo Day

Ten groups of financial technology entrepreneurs presented their innovations to an audience of more than 500 investors, industry experts and journalists.

June 22, 2016

WilmerHale Counsels Zaius in $8M Series B Funding Led by Underscore.VC

Zaius, the only CRM built for the scale and velocity of business-to-consumer marketers, announced it has closed an $8 million investment led by _Underscore.VC, with participation from Leaders Fund and existing investor Matrix Partners.


Skip Navigation Links.


JD, American University, Washington College of Law, 2009, Member, Journal of Gender, Social Policy & the Law

MA, International Economic Policy, American University, 2009

BS, International Business, summa cum laude, University of Rhode Island, 2006

Bar Admissions

New York


Skip Navigation Links.